|
Index of reports
> Cases with Diarrhoea (139)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Dexamethasone where reactions include diarrhoea. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 139 Next >>
Possible Dexamethasone side effects in
Reported by a physician from United States on 2012-08-22
Patient:
Reactions: Abdominal Pain, Thrombosis, Hyperkalaemia, Coagulopathy, Hypoglycaemia, Hypocalcaemia, Hypoxia, Hiccups, Alanine Aminotransferase Abnormal, Pneumonitis, Cough, Pain in Extremity, Hypotension, Hyperglycaemia, External Ear Pain, Haematotoxicity, Dehydration, Lower Gastrointestinal Haemorrhage, Hypofibrinogenaemia, Aspartate Aminotransferase Abnormal, Hypokalaemia, Blood Bilirubin Abnormal, Pleural Effusion, Decreased Appetite, Gamma-Glutamyltransferase Abnormal, Hyponatraemia, Hypercalcaemia, Hypophosphataemia, Diarrhoea, Hypoalbuminaemia, Hypertension, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Asparaginase
Dosage: 2500 units/m2/dose as 4 weekly doses
Indication: Acute Lymphocytic Leukaemia
Bortezomib
Dosage: 1.3 mg/sq.m/dose on days 1, 4, 8 and 11 combined with vxld
Indication: Acute Lymphocytic Leukaemia
Cytarabine
Dosage: on day 1 for all patients and on days 8, 15, 22 for cns invlovment
Indication: Acute Lymphocytic Leukaemia
Dexamethasone
Dosage: 10 mg/m2/day divided in to 2 doses for 14 consecutive days
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Doxorubicin HCL
Dosage: given over 15-30 minutes on day 1
Indication: Acute Lymphocytic Leukaemia
Hydrocortisone
Dosage: on days 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Methotrexate Sodium
Dosage: 1 dose on day 15 for no cns involvement and on days 8, 15, 22 for cns involvement
Indication: Acute Lymphocytic Leukaemia
Vincristine
Dosage: 1.5 mg/m2/dose, max. 2 mg, by push on days 1, 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Other drugs received by patient: Vancomycin; Posaconazole; Voriconazole; Levofloxacin
Possible Dexamethasone side effects in
Reported by a physician from United States on 2012-08-20
Patient:
Reactions: Abdominal Pain, Thrombosis, Hyperkalaemia, Hypoglycaemia, Coagulopathy, Hypokalaemia, Blood Bilirubin Abnormal, Hiccups, Pleural Effusion, Hypoxia, Hypocalcaemia, Alanine Aminotransferase Abnormal, Cough, Pneumonitis, Decreased Appetite, Pain in Extremity, Hypotension, Hyperglycaemia, Gamma-Glutamyltransferase Abnormal, Hyponatraemia, External Ear Pain, Hypercalcaemia, Haematotoxicity, Hypophosphataemia, Diarrhoea, Dehydration, Hypoalbuminaemia, Lower Gastrointestinal Haemorrhage, Hypertension, Hypofibrinogenaemia, Aspartate Aminotransferase Abnormal, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Asparaginase
Dosage: 2500 units/m2/dose as 4 weekly doses
Indication: Acute Lymphocytic Leukaemia
Bortezomib
Dosage: 1.3 mg/sq.m/dose on days 1, 4, 8 and 11 combined with vxld
Indication: Acute Lymphocytic Leukaemia
Cytarabine
Dosage: on day 1 for all patients and on days 8, 15, 22 for cns invlovment
Indication: Acute Lymphocytic Leukaemia
Dexamethasone
Dosage: 10 mg/m2/day divided in to 2 doses for 14 consecutive days
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Doxorubicin Hydrochloride
Dosage: given over 15-30 minutes on day 1
Indication: Acute Lymphocytic Leukaemia
Hydrocortisone
Dosage: on days 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Methotrexate
Dosage: 1 dose on day 15 for no cns involvement and on days 8, 15, 22 for cns involvement
Indication: Acute Lymphocytic Leukaemia
Vincristine
Dosage: 1.5 mg/m2/dose, max. 2 mg, by push on days 1, 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Other drugs received by patient: Levofloxacin; Voriconazole; Posaconazole; Vancomycin
Possible Dexamethasone side effects in
Reported by a physician from France on 2012-08-15
Patient:
Reactions: Diarrhoea
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1672 mg, unk
Indication: Multiple Myeloma
Start date: 2012-06-08
Dexamethasone
Dosage: 20 mg, unk
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-06-08
Velcade
Dosage: 2899 unk, unk
Indication: Multiple Myeloma
Start date: 2012-06-08
Other drugs received by patient: Valaciclovir; Esomeprazole; Atovaquone; Phenoxymethylpenicillin; Sodium Bicarbonate; Allopurinol
Possible Dexamethasone side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-14
Patient:
Reactions: Vomiting, Syncope, Diarrhoea, Nausea, Asthenia, Epistaxis, Haematemesis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Dexamethasone
Dosage: day 22
Administration route: Oral
Dexamethasone
Dosage: day 1
Administration route: Oral
Indication: Multiple Myeloma
Dexamethasone
Dosage: day 8
Administration route: Oral
Dexamethasone
Dosage: day 15
Administration route: Oral
Lenalidomide
Dosage: day 1-21
Administration route: Oral
Indication: Multiple Myeloma
Vorinostat
Dosage: days 1-7
Administration route: Oral
Indication: Multiple Myeloma
Vorinostat
Dosage: days 15-21
Administration route: Oral
Other drugs received by patient: Aspirin
Possible Dexamethasone side effects in
Reported by a physician from United States on 2012-08-14
Patient:
Reactions: Thrombosis, Abdominal Pain, Hyperkalaemia, Hypoglycaemia, Coagulopathy, Hypoxia, Hypocalcaemia, Hiccups, Alanine Aminotransferase Abnormal, Cough, Pneumonitis, Pain in Extremity, Hyperglycaemia, Hypotension, External Ear Pain, Haematotoxicity, Dehydration, Lower Gastrointestinal Haemorrhage, Hypofibrinogenaemia, Aspartate Aminotransferase Abnormal, Hypokalaemia, Neuropathy Peripheral, Blood Bilirubin Abnormal, Pleural Effusion, Decreased Appetite, Hyponatraemia, Gamma-Glutamyltransferase Abnormal, Hypercalcaemia, Hypophosphataemia, Diarrhoea, Hypoalbuminaemia, Hypertension, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Asparaginase
Dosage: 2500 units/m2/dose as 4 weekly doses
Indication: Acute Lymphocytic Leukaemia
Bortezomib
Dosage: 1.3 mg/sq.m/dose on days 1, 4, 8 and 11 combined with vxld
Indication: Acute Lymphocytic Leukaemia
Cytarabine
Dosage: on day 1 for all patients and on days 8, 15, 22 for cns invlovment
Indication: Acute Lymphocytic Leukaemia
Dexamethasone
Dosage: 10 mg/m2/day divided in to 2 doses for 14 consecutive days
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Doxorubicin Hydrochloride
Dosage: given over 15-30 minutes on day 1
Indication: Acute Lymphocytic Leukaemia
Hydrocortisone
Dosage: on days 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Methotrexate
Dosage: 1 dose on day 15 for no cns involvement and on days 8, 15, 22 for cns involvement
Indication: Acute Lymphocytic Leukaemia
Vincristine
Dosage: 1.5 mg/m2/dose, max. 2 mg, by push on days 1, 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Other drugs received by patient: Levofloxacin; Vancomycin; Posaconazole; Voriconazole
Possible Dexamethasone side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-06
Patient:
Reactions: Anaphylactic Reaction, Pyrexia, Headache, Hyperhidrosis, Oedema Peripheral, Cough, Muscle Spasms, Diverticular Perforation, Back Pain, Pneumonia, Anaemia, Insomnia, Neutropenia, Stridor, Chills, Constipation, Hypokalaemia, Disease Progression, Fatigue, Dizziness, Thrombocytopenia, Enteritis, Dyspnoea, Nausea, Lymphopenia, Atrial Fibrillation, Febrile Neutropenia, Rash, Lung Disorder, Diarrhoea, Arthralgia, Sepsis, Bradycardia, Asthenia
Drug(s) suspected as cause:
Dexamethasone
Dosage: 40 milligram
Administration route: Oral
Indication: Multiple Myeloma
Elotuzumab
Dosage: 5, 10 and 20 mg/kg
Indication: Multiple Myeloma
Elotuzumab
Dosage: 5, 10 and 20 mg/kg
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Possible Dexamethasone side effects in
Reported by a physician from Finland on 2012-08-06
Patient:
Reactions: Diarrhoea, Orthostatic Hypotension, Thrombotic Thrombocytopenic Purpura, Haemolytic Uraemic Syndrome
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Dexamethasone
Dosage: 20 mg, cyclic
Indication: Multiple Myeloma
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Multiple Myeloma
Velcade
Dosage: 1.0 mg/m2, cyclic
Possible Dexamethasone side effects in
Reported by a physician from United States on 2012-08-02
Patient:
Reactions: Electrocardiogram QT Prolonged, Hypokalaemia, Hypocalcaemia, Thrombocytopenia, Lethargy, Pneumonia, Nausea, Hyperglycaemia, Atrial Fibrillation, Febrile Neutropenia, Arthralgia, Diarrhoea, Dehydration, Neutropenia, Asthenia, Leukopenia
Drug(s) suspected as cause:
Dexamethasone
Indication: Multiple Myeloma
Lenalidomide
Dosage: 5 or 10mg (daily,days 1-21 of ea cycle)
Administration route: Oral
Indication: Multiple Myeloma
Treanda
Dosage: 75 or 100mg/m2 (day 1 and 2 of ea cycle)
Indication: Multiple Myeloma
Other drugs received by patient: Gastroprotectant; Acetylsalicylic Acid SRT
Possible Dexamethasone side effects in
Reported by a physician from Netherlands on 2012-07-30
Patient:
Reactions: Diarrhoea, Pyrexia
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1000 mg, unk
Indication: Multiple Myeloma
Start date: 2012-05-04
End date: 2012-05-11
Dexamethasone
Dosage: 40 mg, unk
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-05-04
End date: 2012-05-15
Velcade
Dosage: 2.6 mg, unk
Indication: Multiple Myeloma
Start date: 2012-05-04
End date: 2012-05-14
Possible Dexamethasone side effects in 70 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-27
Patient: 70 year old female
Reactions: Diarrhoea, Insomnia
Drug(s) suspected as cause:
Dexamethasone
Revlimid
Indication: Multiple Myeloma
Start date: 2011-02-01
End date: 2012-07-26
Possible Dexamethasone side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-23
Patient:
Reactions: Electrocardiogram QT Prolonged, Hypokalaemia, Hypocalcaemia, Thrombocytopenia, Lethargy, Pneumonia, Nausea, Hyperglycaemia, Febrile Neutropenia, Atrial Fibrillation, Arthralgia, Diarrhoea, Dehydration, Neutropenia, Asthenia, Leukopenia
Drug(s) suspected as cause:
Bendamustine Hydrochloride
Dosage: 75 or 100mg/m2
Indication: Multiple Myeloma
Dexamethasone
Indication: Multiple Myeloma
Revlimid
Dosage: 5 or 10mg
Administration route: Oral
Indication: Multiple Myeloma
Other drugs received by patient: Gastroprotectant; Aspirin
Possible Dexamethasone side effects in 72 year old female
Reported by a health professional (non-physician/pharmacist) from Austria on 2012-07-20
Patient: 72 year old female
Reactions: Bone Pain, Polyuria, Peripheral Sensory Neuropathy, Constipation, Disease Progression, Oedema Peripheral, Dermatitis Bullous, Muscle Spasms, Decreased Appetite, Spinal Fracture, Nausea, Anaemia, Muscular Weakness, Micturition Urgency, Haemoglobin Decreased, Diarrhoea, Visual Impairment, Neutropenia, Hypertension, Herpes Virus Infection, Leukopenia
Drug(s) suspected as cause:
Dexamethasone
Dosage: 40 mg
Administration route: Oral
Indication: Multiple Myeloma
Dexamethasone
Dosage: 12 mg
Administration route: Oral
End date: 2010-03-01
Dexamethasone
Dosage: 40 mg
Administration route: Oral
Dexamethasone
Dosage: 20 mg
Administration route: Oral
Lenalidomide
Dosage: 25 mg
Indication: Multiple Myeloma
Lenalidomide
Dosage: 15 mg
Lenalidomide
Dosage: 10 mg
Lenalidomide
Dosage: 5 mg
End date: 2010-03-01
Pamidronate Disodium
Indication: Multiple Myeloma
Possible Dexamethasone side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-18
Patient:
Reactions: Pneumonia, Nausea, Lymphopenia, Hyperglycaemia, Anaemia, Febrile Neutropenia, Constipation, Renal Failure, Neuropathy Peripheral, Fatigue, Diarrhoea, Embolism, Neutropenia, Thrombocytopenia, Deep Vein Thrombosis
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 500 milligram/sq. meter
Indication: Multiple Myeloma
Dexamethasone
Dosage: 40 milligram
Indication: Multiple Myeloma
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Revlimid
Dosage: 15 milligram
Administration route: Oral
Velcade
Dosage: 1.3 milligram/sq. meter
Indication: Multiple Myeloma
Velcade
Dosage: 1.3 milligram/sq. meter
Possible Dexamethasone side effects in 55 year old male
Reported by a physician from United Kingdom on 2012-07-16
Patient: 55 year old male, weighing 71.4 kg (157.1 pounds)
Reactions: Drug Ineffective, Diarrhoea, Multiple Myeloma
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Dexamethasone
Dosage: 160 mg, qmo
Administration route: Oral
Start date: 2010-10-18
End date: 2010-11-09
Dexamethasone
Dosage: 160 mg, qmo
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-09-27
End date: 2010-10-17
Doxorubicin HCL
Dosage: 64 mg, qmo
Start date: 2010-10-18
End date: 2010-11-09
Doxorubicin HCL
Dosage: 64 mg/h, qmo
Indication: Multiple Myeloma
Start date: 2010-09-27
End date: 2010-10-17
Velcade
Start date: 2010-10-18
End date: 2010-11-10
Velcade
Indication: Multiple Myeloma
Start date: 2010-09-27
Other drugs received by patient: Amoxicillin; Gabapentin; Acetaminophen; Furosemide; Enoxaparin Sodium
Possible Dexamethasone side effects in
Reported by a individual with unspecified qualification from United Kingdom on 2012-07-13
Patient:
Reactions: Diarrhoea, Multiple Myeloma
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Dexamethasone
Dosage: 160 mg, unk
Administration route: Oral
Start date: 2010-10-18
End date: 2010-11-09
Dexamethasone
Dosage: 160 mg, unk
Administration route: Oral
Indication: Prophylaxis
Start date: 2010-09-27
End date: 2010-10-17
Doxorubicin HCL
Dosage: 64 mg, unknown
Start date: 2010-10-18
End date: 2010-11-09
Doxorubicin HCL
Dosage: 64 mg, unknown
Indication: Polyuria
Start date: 2010-09-27
End date: 2010-10-17
Velcade
Dosage: 2.4 mg/m2, unknown
Indication: Anti-Infective Therapy
Start date: 2010-09-27
Velcade
Dosage: 2.4 mg/m2, unknown
Start date: 2010-10-18
End date: 2010-11-09
Other drugs received by patient: Acetaminophen; MK-0805; Gabapentin; Amoxicillin; MK-0805; Enoxaparin Sodium; Bebetina
Possible Dexamethasone side effects in
Reported by a physician from Austria on 2012-07-12
Patient:
Reactions: Bone Pain, Polyuria, Multiple Myeloma, Peripheral Sensory Neuropathy, Constipation, Oedema Peripheral, Dermatitis Bullous, Muscle Spasms, Decreased Appetite, Nausea, Anaemia, Muscular Weakness, Lumbar Vertebral Fracture, Micturition Urgency, Diarrhoea, Visual Impairment, Neutropenia, Hypertension, Herpes Virus Infection, Leukopenia
Drug(s) suspected as cause:
Dexamethasone
Dosage: 40 mg, on days 1-4, 9-12, and 17-20 for the first four cycles and on days 1-4 thereafter
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2004-06-01
End date: 2005-10-01
Dexamethasone
Dosage: 20 mg on days 1-4 of each cycle
Administration route: Oral
Dexamethasone
Dosage: 12 mg on days 1-4 of each cycle
Administration route: Oral
End date: 2010-03-01
Lenalidomide
Dosage: 25 mg, on days 1-21 of each 28-day cycle
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2005-11-01
Lenalidomide
Dosage: 15 mg daily on days 1-21
Administration route: Oral
End date: 2010-03-01
Lenalidomide
Dosage: 10 mg, daily on days 1-21
Administration route: Oral
Lenalidomide
Dosage: 5 mg, daily on days 1-21
Administration route: Oral
End date: 2010-03-01
Other drugs received by patient: Pamidronate Disodium
Possible Dexamethasone side effects in
Reported by a physician from Netherlands on 2012-07-12
Patient:
Reactions: Diarrhoea, Pyrexia
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1000 mg, unk
Indication: Multiple Myeloma
Start date: 2012-05-04
End date: 2012-05-11
Dexamethasone
Dosage: 40 mg, unk
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-05-04
End date: 2012-05-15
Velcade
Dosage: 2.6 mg, unk
Indication: Multiple Myeloma
Start date: 2012-05-04
End date: 2012-05-14
Possible Dexamethasone side effects in 55 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-07-03
Patient: 55 year old male
Reactions: Diarrhoea, Neoplasm Progression, Multiple Myeloma
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Dexamethasone
Dosage: 160 mg; ;po
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-09-27
End date: 2010-10-17
Dexamethasone
Dosage: 160 mg; ;po
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-10-18
End date: 2010-11-09
Doxorubicin HCL
Dosage: 64 mg; iv
Indication: Multiple Myeloma
Start date: 2010-09-27
End date: 2010-10-17
Doxorubicin HCL
Dosage: 64 mg; iv
Indication: Multiple Myeloma
Start date: 2010-10-10
End date: 2010-11-09
Velcade
Dosage: 2.4 mg/m2; ;iv
Indication: Multiple Myeloma
Start date: 2010-09-27
Velcade
Dosage: 2.4 mg/m2; ;iv
Indication: Multiple Myeloma
Start date: 2010-10-18
End date: 2010-11-09
Other drugs received by patient: Amoxicillin; Gabapentin; Furosemide; Acetaminophen; Enoxaparin Sodium; Furosemide
Possible Dexamethasone side effects in 62 year old male
Reported by a physician from United Kingdom on 2012-07-03
Patient: 62 year old male
Reactions: Fatigue, Diarrhoea, Nausea, Pulmonary Embolism, Electrolyte Imbalance, Lower Respiratory Tract Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Dexamethasone
Dosage: 160 mg;;po
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-01-05
End date: 2010-02-26
Velcade
Dosage: 2.5 mg;;iv, 1.3 mg;;iv
Indication: Multiple Myeloma
Start date: 2010-03-29
End date: 2010-03-29
Velcade
Dosage: 2.5 mg;;iv, 1.3 mg;;iv
Indication: Multiple Myeloma
Start date: 2010-01-05
Other drugs received by patient: Acyclovir; Fluconazole; Dexamethasone; Fentanyl; Furosemide; Lansoprazole; Melphalan Hydrochloride; Vincristine; Doxorubicin HCL; Metformin Hydrochloride; Pioglitazone; Cyclophosphamide; Thalidomide; Glimepiride
Possible Dexamethasone side effects in female
Reported by a physician from United States on 2012-06-29
Patient: female, weighing 77.0 kg (169.4 pounds)
Reactions: Diarrhoea
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Dexamethasone
Start date: 2012-05-25
Lenalidomide
Start date: 2012-05-25
Treanda
Dosage: days 1-2
Indication: Multiple Myeloma
Start date: 2012-05-25
End date: 2012-05-26
Other drugs received by patient: Oxycodone HCL; Metoprolol Succinate; Potassium Chloride; Amitriptyline HCL; Warfarin Sodium; Senokot; Duloxetime Hydrochloride; Vitacal / 01535001 /; Zolpidem Tartrate; Oxycodone Hydrochloride; Omeprazole; Furosemide; Calcium Acetate; Allopurinol; Pamidronate Disodium; Acetylsalicylic Acid SRT; Acyclovir; Bactrim; Phenoxymethyl Penicillin
Possible Dexamethasone side effects in
Reported by a physician from Serbia on 2012-06-29
Patient:
Reactions: Malaise, Hyperpyrexia, Hypoproteinaemia, Diarrhoea, Hypotension, Pseudomembranous Colitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Adriablastin
Dosage: unk
Indication: Multiple Myeloma
Start date: 2011-11-23
End date: 2012-03-01
Amikacin
Dexamethasone
Dosage: unk
Indication: Multiple Myeloma
Start date: 2011-11-23
End date: 2012-03-01
Meropenem
Vancomycin
Velcade
Dosage: 1.3 mg, unk
Indication: Multiple Myeloma
End date: 2012-03-01
Other drugs received by patient: Diunorm; Losartan Potassium; Norvasc; Pantoprazole
Possible Dexamethasone side effects in 55 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-06-29
Patient: 55 year old male, weighing 71.4 kg (157.1 pounds)
Reactions: Diarrhoea, Drug Ineffective, Neoplasm Progression, Multiple Myeloma
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Dexamethasone
Dosage: 160 gm;qm;po ; 160 mg;qm;po
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-10-18
End date: 2010-11-09
Dexamethasone
Dosage: 160 gm;qm;po ; 160 mg;qm;po
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-09-27
End date: 2010-10-17
Doxorubicin HCL
Dosage: 64 mg;qm;iv ; 64 mg;qm;iv
Indication: Multiple Myeloma
Start date: 2010-09-27
End date: 2010-10-17
Doxorubicin HCL
Dosage: 64 mg;qm;iv ; 64 mg;qm;iv
Indication: Multiple Myeloma
Start date: 2010-10-18
End date: 2010-11-09
Velcade
Dosage: iv ; iv
Indication: Multiple Myeloma
Start date: 2010-09-27
Velcade
Dosage: iv ; iv
Indication: Multiple Myeloma
Start date: 2010-10-18
End date: 2010-11-10
Other drugs received by patient: Enoxaparin Sodium; Gabapentin; Amoxicillin; Acetaminophen
Possible Dexamethasone side effects in
Reported by a physician from Japan on 2012-06-29
Patient:
Reactions: Nausea, Anaemia, Febrile Neutropenia, Hyponatraemia, Toxicity To Various Agents, Peripheral Sensory Neuropathy, Haematotoxicity, Hypokalaemia, Fatigue, Diarrhoea, Neutropenia, Thrombocytopenia
Drug(s) suspected as cause:
Bortezomib
Dosage: days 1, 4, 8 and 11 (1 mg/ m2 in cohort 1 and 1.3 mg/ m2 in cohort 2)
Indication: Multiple Myeloma
Dexamethasone
Dosage: days 1-2, 4-5, 8-9 and 11-12
Administration route: Oral
Indication: Multiple Myeloma
Doxorubicin HCL
Dosage: days 1-4
Doxorubicin HCL
Dosage: days 1-4
Indication: Multiple Myeloma
Possible Dexamethasone side effects in
Reported by a physician from United States on 2012-06-28
Patient:
Reactions: Fatigue, Central Nervous System Haemorrhage, Erythema Multiforme, Vomiting, Stomatitis, Dyspnoea, Gastrointestinal Toxicity, Nausea, Condition Aggravated, Rash, Haematotoxicity, Pulmonary Haemorrhage, Tumour Lysis Syndrome, Respiratory Failure, Diarrhoea, Neurological Symptom, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: days 1-5 during cycle 3,5 and 7
Cyclophosphamide
Dosage: days 1-5 during cycle 3,5 and 7
Cyclophosphamide
Dosage: for 5 days in cycle 1
Indication: Burkitt's Leukaemia
Cyclophosphamide
Dosage: for 5 days in cycle 1
Indication: Burkitt's Lymphoma
Cytarabine
Dosage: on days 4 and 5 of cycle 2,4 and 6
Indication: Burkitt's Lymphoma
Cytarabine
Dosage: on days 4 and 5 of cycle 2,4 and 6
Indication: Burkitt's Leukaemia
Dexamethasone
Dosage: on days 1-5 of cycle 2,4 and 6
Dexamethasone
Dosage: on days 1-5 of cycle 2,4 and 6
Dexamethasone
Dosage: on days 1-5 of cycle 3,5 and 7
Indication: Burkitt's Lymphoma
Dexamethasone
Dosage: on days 1-5 of cycle 3,5 and 7
Indication: Burkitt's Leukaemia
Doxorubicin HCL
Dosage: on days 4 and 5 of cycle 3,5 and 7
Indication: Burkitt's Lymphoma
Doxorubicin HCL
Dosage: on days 4 and 5 of cycle 3,5 and 7
Indication: Burkitt's Leukaemia
Etoposide
Dosage: on days 4 and 5 of cycle 2,4 and 6
Indication: Burkitt's Leukaemia
Etoposide
Dosage: on days 4 and 5 of cycle 2,4 and 6
Indication: Burkitt's Lymphoma
Ifosfamide
Dosage: on days 1-5 in cycle 2,4 and 6
Indication: Burkitt's Lymphoma
Ifosfamide
Dosage: on days 1-5 in cycle 2,4 and 6
Indication: Burkitt's Leukaemia
Methotrexate
Dosage: on day 1 of cycle 3,5 and 7
Indication: Burkitt's Lymphoma
Methotrexate
Dosage: on day 1 of cycle 2,4 and 6
Methotrexate
Dosage: on day 1 of cycle 3,5 and 7
Methotrexate
Dosage: on day 1 of cycle 2,4 and 6
Indication: Burkitt's Leukaemia
Prednisone TAB
Dosage: for 7 days in cycle 1
Indication: Burkitt's Leukaemia
Prednisone TAB
Dosage: for 7 days in cycle 1
Indication: Burkitt's Lymphoma
Rituximab
Dosage: on day 8 from cycle 3 to 7
Rituximab
Dosage: day 8 on cycle 2; doage increased to 375 mg/m2 on day 10 and 12
Indication: Burkitt's Leukaemia
Rituximab
Dosage: day 8 on cycle 2; doage increased to 375 mg/m2 on day 10 and 12
Indication: Burkitt's Lymphoma
Rituximab
Dosage: on day 8 from cycle 3 to 7
Vincristine
Dosage: on day 1 of cycle 2,4 and 6
Vincristine
Dosage: on day 1 of cycle 2,4 and 6
Indication: Burkitt's Leukaemia
Vincristine
Dosage: on day 1 of cycle 3,5 and 7
Vincristine
Dosage: on day 1 of cycle 3,5 and 7
Indication: Burkitt's Lymphoma
Other drugs received by patient: Unknown Medication; Leucovorin Calcium; Filgrastim
Possible Dexamethasone side effects in
Reported by a physician from Japan on 2012-06-28
Patient:
Reactions: Nausea, Anaemia, Febrile Neutropenia, Hyponatraemia, Toxicity To Various Agents, Peripheral Sensory Neuropathy, Haematotoxicity, Hypokalaemia, Fatigue, Diarrhoea, Neutropenia, Thrombocytopenia
Drug(s) suspected as cause:
Bortezomib
Dosage: days 1, 4, 8 and 11 (1 mg/ m2 in cohort 1 and 1.3 mg/ m2 in cohort 2)
Indication: Multiple Myeloma
Dexamethasone
Dosage: days 1-2, 4-5, 8-9 and 11-12
Administration route: Oral
Indication: Multiple Myeloma
Doxorubicin HCL
Dosage: days 1-4
Doxorubicin HCL
Dosage: days 1-4
Indication: Multiple Myeloma
Possible Dexamethasone side effects in
Reported by a physician from Japan on 2012-06-27
Patient:
Reactions: Nausea, Anaemia, Febrile Neutropenia, Hyponatraemia, Toxicity To Various Agents, Peripheral Sensory Neuropathy, Haematotoxicity, Hypokalaemia, Fatigue, Diarrhoea, Neutropenia, Thrombocytopenia
Drug(s) suspected as cause:
Bortezomib
Dosage: days 1, 4, 8 and 11 (1 mg/ m2 in cohort 1 and 1.3 mg/ m2 in cohort 2)
Indication: Multiple Myeloma
Dexamethasone
Dosage: days 1-2, 4-5, 8-9 and 11-12
Administration route: Oral
Indication: Multiple Myeloma
Doxorubicin HCL
Dosage: days 1-4
Indication: Multiple Myeloma
Possible Dexamethasone side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-25
Patient:
Reactions: Fatigue, Central Nervous System Haemorrhage, Erythema Multiforme, Stomatitis, Vomiting, Dyspnoea, Nausea, Gastrointestinal Toxicity, Condition Aggravated, Rash, Haematotoxicity, Pulmonary Haemorrhage, Tumour Lysis Syndrome, Diarrhoea, Respiratory Failure, Neurological Symptom, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: for 5 days in cycle 1
Indication: Burkitt's Lymphoma
Cyclophosphamide
Dosage: days 1-5 during cycle 3,5 and 7
Cyclophosphamide
Dosage: days 1-5 during cycle 3,5 and 7
Cyclophosphamide
Dosage: for 5 days in cycle 1
Indication: Burkitt's Leukaemia
Cytarabine
Dosage: on days 4 and 5 of cycle 2,4 and 6
Indication: Burkitt's Leukaemia
Cytarabine
Dosage: on days 4 and 5 of cycle 2,4 and 6
Indication: Burkitt's Lymphoma
Dexamethasone
Dosage: on days 1-5 of cycle 3,5 and 7
Indication: Burkitt's Lymphoma
Dexamethasone
Dosage: on days 1-5 of cycle 2,4 and 6
Dexamethasone
Dosage: on days 1-5 of cycle 3,5 and 7
Indication: Burkitt's Leukaemia
Dexamethasone
Dosage: on days 1-5 of cycle 2,4 and 6
Doxorubicin HCL
Dosage: on days 4 and 5 of cycle 3,5 and 7
Indication: Burkitt's Lymphoma
Doxorubicin HCL
Dosage: on days 4 and 5 of cycle 3,5 and 7
Indication: Burkitt's Leukaemia
Etoposide
Dosage: on days 4 and 5 of cycle 2,4 and 6
Indication: Burkitt's Lymphoma
Etoposide
Dosage: on days 4 and 5 of cycle 2,4 and 6
Indication: Burkitt's Leukaemia
Ifosfamide
Dosage: on days 1-5 in cycle 2,4 and 6
Indication: Burkitt's Lymphoma
Ifosfamide
Dosage: on days 1-5 in cycle 2,4 and 6
Indication: Burkitt's Leukaemia
Methotrexate
Dosage: on day 1 of cycle 2,4 and 6
Indication: Burkitt's Leukaemia
Methotrexate
Dosage: on day 1 of cycle 3,5 and 7
Methotrexate
Dosage: on day 1 of cycle 2,4 and 6
Methotrexate
Dosage: on day 1 of cycle 3,5 and 7
Indication: Burkitt's Lymphoma
Prednisone TAB
Dosage: for 7 days in cycle 1
Indication: Burkitt's Lymphoma
Prednisone TAB
Dosage: for 7 days in cycle 1
Indication: Burkitt's Leukaemia
Rituximab
Dosage: on day 8 from cycle 3 to 7
Rituximab
Dosage: on day 8 from cycle 3 to 7
Rituximab
Dosage: day 8 on cycle 2; doage increased to 375 mg/m2 on day 10 and 12
Indication: Burkitt's Leukaemia
Rituximab
Dosage: day 8 on cycle 2; doage increased to 375 mg/m2 on day 10 and 12
Indication: Burkitt's Lymphoma
Vincristine
Dosage: on day 1 of cycle 2,4 and 6
Indication: Burkitt's Leukaemia
Vincristine
Dosage: on day 1 of cycle 2,4 and 6
Vincristine
Dosage: on day 1 of cycle 3,5 and 7
Vincristine
Dosage: on day 1 of cycle 3,5 and 7
Indication: Burkitt's Lymphoma
Other drugs received by patient: Unknown Medication; Leucovorin Calcium; Filgrastim
Possible Dexamethasone side effects in 64 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-06-22
Patient: 64 year old male
Reactions: Diarrhoea, Electrolyte Imbalance
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Bendamustine Hydrochloride
Indication: Multiple Myeloma
Start date: 2011-09-28
End date: 2012-05-09
Bendamustine Hydrochloride
Dexamethasone
Indication: Multiple Myeloma
Thalidomide
Indication: Multiple Myeloma
Other drugs received by patient: Fluconazole; Cotrim; Lansoprazole; Acyclovir; Ondansetron
Possible Dexamethasone side effects in female
Reported by a physician from United States on 2012-06-21
Patient: female, weighing 50.4 kg (110.9 pounds)
Reactions: Abdominal Pain Lower, Vomiting, Diarrhoea, Nausea, Sepsis, Ventricular Tachycardia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Dexamethasone
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-01-24
End date: 2012-03-13
Other drugs received by patient: Benazepril Hydrochloride; Ferrous Fumarate; Simvastatin; Amlodipine; Iron; Calcium; Aspirin; Cytoxan
Possible Dexamethasone side effects in 64 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-06-20
Patient: 64 year old male
Reactions: Diarrhoea, Electrolyte Imbalance, Blood Magnesium Decreased, Hypokalaemia
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Bendamustine Hydrochloride
Dosage: 100 mg/m2;iv 50 mg/m2;iv
Indication: Multiple Myeloma
Start date: 2011-09-28
End date: 2012-05-09
Dexamethasone
Indication: Multiple Myeloma
Thalidomide
Indication: Multiple Myeloma
Other drugs received by patient: Acyclovir; Ondansetron; Cotrim; Fluconazole; Lansoprazole
Page 1 Next >>
|
